Download: Considerations in building a pipeline of mAb biosimilars for emerging markets


Download this presentation here >

The World Biosimilar Congress  brings together pharma, biotech, academia and regulators and the wider service provider community to discuss the latest R&D, process, production, regulation and to-market strategies for biosimilar medicines.

At the 2013 event, delegates were fortunate enough to hear from Dr Roman Ivanov, Vice President, R&D, BIOCAD, who delivered the presentation ‘Considerations in building a pipeline of mAb biosimilars for Asian, Russian and Latin American markets – overcoming challenges in emerging markets‘.

Download this presentation here >

If you’re interested in in learning more and engaging in discussion on biosimilar medicines, you might want to check out the World Biosimilar Congress 2014 – preparations are in full swing! Make sure you’re keeping up to date on the latest developments in this exciting market.

Leave a Reply

Your email address will not be published. Required fields are marked *